Abstract
As abundant types of genetic predisposition and environmental factors seem to be associated with the development of juvenile-onset systemic lupus erythematosus (JSLE), we investigated the gene polymorphisms of two anti-inflammatory cytokines, including interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β), which were previously found to be associated with SLE in adults, in a group of patients with JSLE. We studied a group of 59 Iranian patients with JSLE in comparison with 140 healthy controls and assessed the frequency of alleles, genotypes, and haplotypes of IL-10 and TGF-β single-nucleotide polymorphisms (SNPs) using polymerase chain reaction with sequence-specific primers method. The CA genotype was significantly more frequent at position −592 in IL-10 in patients with juvenile-onset systemic lupus erythematosus than in the controls (P = 0.01). Genotype CC was detected at the same position in 32.7 % of the patients; this frequency was significantly lower than the frequency of 50.7 % recorded in the healthy controls (P = 0.03). The TC haplotype of TGF-β (codon 10, codon 25) was significantly more frequent in the patients with juvenile-onset systemic lupus erythematosus than in the healthy controls (P = 0.02). Nevertheless, these significant associations disappear after Bonferroni correction. Our findings suggest that IL-10 (−1082, −819, −592) and TGF-β (codon 10, codon 25) gene variants may not be associated with the development of JSLE in Iranian population.
Similar content being viewed by others
References
Yap DYH, Lai KN (2013) The role of cytokines in the pathogenesis of systemic lupus erythematosus—from bench to bedside. Nephrol 18:243–255
Klein-Gitelman M, Reiff A, Silverman ED (2002) Systemic lupus erythematosus in childhood. Rheum Dis Clin N Am 28:561–577
Tucker L, Menon S, Schaller J, Isenberg D (1995) Adult-and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Rheumatology 34:866–872
Lee P, Lee T-L, Ho M-K, Wong W, Lau Y-L (2007) Recurrent major infections in juvenile-onset systemic lupus erythematosus—a close link with long-term disease damage. Rheumatology 46:1290–1296
Perfumo F, Martini A (2005) Lupus nephritis in children. Lupus 14:83–88
Costallat L, Coimbra A (1993) Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol 12:603–607
Tsao BP (2004) Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 16:513–521
Yoshimura A, Wakabayashi Y, Mori T (2010) Cellular and molecular basis for the regulation of inflammation by TGF-β. J Biochem 147:781–792
Li MO, Wan YY, Sanjabi S, Robertson A-KL, Flavell RA (2006) Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 24:99–146
Su D-L, Lu Z-M, Shen M-N, Li X, Sun L-Y (2012) Roles of pro-and anti-inflammatory cytokines in the pathogenesis of SLE. BioMed Research International 2012
Park Y, Lee S, Kim D, Lee J, Lee C, Song C (1997) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 16:283–288
Miyake K, Nakashima H, Akahoshi M et al (2002) Genetically determined interferon‐γ production influences the histological phenotype of lupus nephritis. Rheumatology 41:518–524
Ohtsuka K, Gray J, Stimmler M, Horwitz D (1999) The relationship between defects in lymphocyte production of transforming growth factor-β1 in systemic lupus erythematosus and disease activity or severity. Lupus 8:90–94
Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166:3915–3922
Rood M, Van Krugten M, Zanelli E et al (2000) TNF‐308A and HLA–DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 43:129–134
Amirzargar A, Shahram F, Nikoopour E et al (2010) Proinflammatory cytokine gene polymorphisms in Behcet’s disease. Eur Cytokine Netw 21:292–296
Mahdaviani SA, Rezaei N, Moradi B, Dorkhosh S, Amirzargar AA, Movahedi M (2009) Proinflammatory cytokine gene polymorphisms among Iranian patients with asthma. J Clin Immunol 29:57–62
Rezaei N, Amirzargar AA, Shakiba Y, Mahmoudi M, Moradi B, Aghamohammadi A (2009) Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol 155:21–27
Amirzargar AA, Bagheri M, Ghavamzadeh A et al (2005) Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. Int J Immunogenet 32:167–171
Amirzargar AA, Rezaei N, Jabbari H et al (2006) Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. Eur Cytokine Netw 17:84–89
Ziaee V, Tahghighi F, Moradinejad MH et al (2014) Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in Iranian patients with juvenile systemic lupus erythematosus. Eur Cytokine Netw 25:35–40
Mahmoudi M, Tahghighi F, Ziaee V et al (2014) Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Int J Immunogenet 41:512–517
Khoa PD, Sugiyama T, Yokochi T (2005) Polymorphism of interleukin-10 promoter and tumor necrosis factor receptor II in Vietnamese patients with systemic lupus erythematosus. Clin Rheumatol 24:11–13
da Silva HDA, da Silva AP, da Silva HA, Asano NMJ, Maia MdMD, de Souza PRE (2014) Interferon gamma and Interleukin 10 polymorphisms in Brazilian patients with systemic lupus erythematosus. Molecular biology reports 1–8
Rianthavorn P, Chokedeemeeboon C, Deekajorndech T, Suphapeetiporn K (2013) Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus. Lupus 22:721–726
Chong W, Ip W, Wong WH, Lau C, Chan T, Lau Y (2004) Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun 5:484–492
Mok CC, Lanchbury JS, Chan DW, Lau CS (1998) Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 41:1090–1095
Giordano M, Mellai M, Lanceni M et al (2002) Association tests with systemic lupus erythematosus (SLE) of IL10 markers indicate a direct involvement of a CA repeat in the 5′ regulatory region. Genes Immun 3:454–463
Dijstelbloem HM, Hepkema BG, Kallenberg CG et al (2002) The R-H polymorphism of FCgamma receptor IIa as a risk factor for systemic lupus erythematosus is independent of single-nucleotide polymorphisms in the interleukin-10 gene promoter. Arthritis Rheum 46:1125–1126
Schotte H, Willeke P, Rust S et al (2003) The transforming growth factor-β1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus. Lupus 12:86–92
Wang B, Morinobu A, Kanagawa S, Koshiba M, Hashimoto H, Kumagai S (2007) Transforming growth factor beta 1 gene polymorphism in Japanese patients with systemic lupus erythematosus. Kobe J Med Sci 53:15–23
Lu LY, Cheng HH, Sung PK, Yeh JJ, Shiue YL, Chen A (2004) Single-nucleotide polymorphisms of transforming growth factor-beta1 gene in Taiwanese patients with systemic lupus erythematosus. J Microbiol Immunol Infect = Wei Mian yu gan ran za zhi 37:145–152
Amirzargar AA, Naroueynejad M, Khosravi F et al (2008) Cytokine single nucleotide polymorphisms in Iranian populations. Eur Cytokine Netw 19:104–112
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725–1725
Miller S, Dykes D, Polesky H (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 289–300
Hoffmann SC, Stanley EM, Cox ED et al (2001) Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-cd3/cd28-stimulated peripheral blood lymphocytes1. Transplantation 72:1444–1450
Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGF-β*. Annu Rev Immunol 16:137–161
Wahl SM (1994) Transforming growth factor beta: the good, the bad, and the ugly. J Exp Med 180:1587–1590
Huggins M, Todd I, Cavers M, Pavuluri S, Tighe P, Powell R (1999) Antibodies from systemic lupus erythematosus (SLE) sera define differential release of autoantigens from cell lines undergoing apoptosis. Clin Exp Immunol 118:322
Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Inv 101:890
Grainger DJ, Heathcote K, Chiano M et al (1999) Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet 8:93–97
Guarnizo Zuccardi P, Lopez Y, Giraldo M et al (2007) Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens 70:376–382
Mosmann TR (1994) Properties and functions of interleukin-10. Adv Immunol 56:1–26
de Waal MR, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220
Rousset F, Garcia E, Defrance T et al (1992) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci 89:1890–1893
Levy Y, Brouet J-C (1994) Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Inv 93:424
Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet : Off J Br Soc Histocompatibility Immunogenet 24:1–8
Kindt S, Van Oudenhove L, Broekaert D et al (2009) Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil : Off J Eur Gastrointest Motil Soc 21:389–398
Hua MC, Chao HC, Yao TC, Lai MW, Huang JL (2013) Investigation of interleukin-10 promoter polymorphisms and interleukin-10 levels in children with irritable bowel syndrome. Gut Liver 7:430–436
Suárez A, López P, Mozo L, Gutiérrez C (2005) Differential effect of IL10 and TNFα genotypes on determining susceptibility to discoid and systemic lupus erythematosus. Ann Rheum Dis 64:1605–1610
Crawley E, Woo P, Isenberg DA (1999) Single nucleotide polymorphic haplotypes of the interleukin‐10 5′ flanking region are not associated with renal disease or serology in caucasian patients with systemic lupus erythematosus. Arthritis Rheum 42:2017–2018
Lazarus M, Hajeer A, Turner D et al (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 24:2314–2317
Sung Y-K, Park B, Shin H, Kim L, Kim S-Y, Bae S-C (2006) Interleukin-10 gene polymorphisms are associated with the SLICC/ACR Damage Index in systemic lupus erythematosus. Rheumatology 45:400–404
Hirankarn N, Wongpiyabovorn J, Hanvivatvong O et al (2006) The synergistic effect of FC gamma receptor IIa and interleukin‐10 genes on the risk to develop systemic lupus erythematosus in Thai population. Tissue Antigens 68:399–406
Lin Y, Wan L, Huang C et al (2010) L-10 and TNF-alpha promoter polymorphisms in susceptibility to systemic lupus erythematosus in Taiwan. Clin Exp Rheumatol 28:318–324
Rosado S, Rua-Figueroa I, Vargas J et al (2008) Interleukin‐10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands. Int J Immunogenet 35:235–242
Acknowledgments
This study was supported by a grant (no. 18261) from Tehran University of Medical Sciences.
Conflicts of interest
The authors report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rezaei, A., Ziaee, V., Sharabian, F.T. et al. Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus. Clin Rheumatol 34, 1059–1064 (2015). https://doi.org/10.1007/s10067-015-2877-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-015-2877-2